Global OTC Pharmaceuticals
Published: August 2013 · Publisher: MarketLine
Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017).
- Description
- Companies Mentioned
- Table of Contents
- Ask a Question
Introduction
Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.
*The global OTC pharmaceuticals market had total revenues of $132,178.0m in 2012, representing a compound annual growth rate (CAGR) of 3.7% between 2008 and 2012.
*The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $26,066.8m, equivalent to 19.7% of the market's overall value.
*The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.1% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $161,260.2m by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in the global
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalotc pharmaceuticals market
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Global otc pharmaceuticals market with five year forecasts by both value and volume
Key Questions Answered
What was the size of the Global otc pharmaceuticals market by value in 2012?
What will be the size of the Global otc pharmaceuticals market in 2017?
What factors are affecting the strength of competition in the Global otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in the global's otc pharmaceuticals market?
Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2012 annual average exchange rates.
*The global OTC pharmaceuticals market had total revenues of $132,178.0m in 2012, representing a compound annual growth rate (CAGR) of 3.7% between 2008 and 2012.
*The traditional medicines segment was the market's most lucrative in 2012, with total revenues of $26,066.8m, equivalent to 19.7% of the market's overall value.
*The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.1% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $161,260.2m by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in the global
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalotc pharmaceuticals market
Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Global otc pharmaceuticals market with five year forecasts by both value and volume
Key Questions Answered
What was the size of the Global otc pharmaceuticals market by value in 2012?
What will be the size of the Global otc pharmaceuticals market in 2017?
What factors are affecting the strength of competition in the Global otc pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in the global's otc pharmaceuticals market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Bayer AG, GlaxoSmithKline Plc, Johnson & Johnson and Novartis AG
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market share 11
Market distribution 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Bayer AG 20
GlaxoSmithKline Plc 24
Johnson & Johnson 28
Novartis AG 31
Appendix 35
Methodology 35
Industry associations 36
Related research 36
LIST OF TABLES
Table 1: Global OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2012 10
Table 4: Global OTC pharmaceuticals market share: % share, by value, 2012 11
Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2012 12
Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Table 7: Bayer AG: key facts 20
Table 8: Bayer AG: key financials ($) 21
Table 9: Bayer AG: key financials (€) 21
Table 10: Bayer AG: key financial ratios 22
Table 11: GlaxoSmithKline Plc: key facts 24
Table 12: GlaxoSmithKline Plc: key financials ($) 25
Table 13: GlaxoSmithKline Plc: key financials (£) 26
Table 14: GlaxoSmithKline Plc: key financial ratios 26
Table 15: Johnson & Johnson: key facts 28
Table 16: Johnson & Johnson: key financials ($) 29
Table 17: Johnson & Johnson: key financial ratios 29
Table 18: Novartis AG: key facts 31
Table 19: Novartis AG: key financials ($) 32
Table 20: Novartis AG: key financial ratios 33
LIST OF FIGURES
Figure 1: Global OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2012 10
Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2012 11
Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2012 12
Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2012 14
Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2012 15
Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2012 16
Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2012 17
Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2012 18
Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2012 19
Figure 13: Bayer AG: revenues & profitability 22
Figure 14: Bayer AG: assets & liabilities 23
Figure 15: GlaxoSmithKline Plc: revenues & profitability 26
Figure 16: GlaxoSmithKline Plc: assets & liabilities 27
Figure 17: Johnson & Johnson: revenues & profitability 29
Figure 18: Johnson & Johnson: assets & liabilities 30
Figure 19: Novartis AG: revenues & profitability 33
Figure 20: Novartis AG: assets & liabilities 34
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market share 11
Market distribution 12
Market Outlook 13
Market value forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
Bayer AG 20
GlaxoSmithKline Plc 24
Johnson & Johnson 28
Novartis AG 31
Appendix 35
Methodology 35
Industry associations 36
Related research 36
LIST OF TABLES
Table 1: Global OTC pharmaceuticals market value: $ million, 2008–12 8
Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2012 9
Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2012 10
Table 4: Global OTC pharmaceuticals market share: % share, by value, 2012 11
Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2012 12
Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Table 7: Bayer AG: key facts 20
Table 8: Bayer AG: key financials ($) 21
Table 9: Bayer AG: key financials (€) 21
Table 10: Bayer AG: key financial ratios 22
Table 11: GlaxoSmithKline Plc: key facts 24
Table 12: GlaxoSmithKline Plc: key financials ($) 25
Table 13: GlaxoSmithKline Plc: key financials (£) 26
Table 14: GlaxoSmithKline Plc: key financial ratios 26
Table 15: Johnson & Johnson: key facts 28
Table 16: Johnson & Johnson: key financials ($) 29
Table 17: Johnson & Johnson: key financial ratios 29
Table 18: Novartis AG: key facts 31
Table 19: Novartis AG: key financials ($) 32
Table 20: Novartis AG: key financial ratios 33
LIST OF FIGURES
Figure 1: Global OTC pharmaceuticals market value: $ million, 2008–12 8
Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2012 9
Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2012 10
Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2012 11
Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2012 12
Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 2012–17 13
Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2012 14
Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2012 15
Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2012 16
Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2012 17
Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2012 18
Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2012 19
Figure 13: Bayer AG: revenues & profitability 22
Figure 14: Bayer AG: assets & liabilities 23
Figure 15: GlaxoSmithKline Plc: revenues & profitability 26
Figure 16: GlaxoSmithKline Plc: assets & liabilities 27
Figure 17: Johnson & Johnson: revenues & profitability 29
Figure 18: Johnson & Johnson: assets & liabilities 30
Figure 19: Novartis AG: revenues & profitability 33
Figure 20: Novartis AG: assets & liabilities 34
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.